Stocks and Investing Stocks and Investing
Mon, January 13, 2020
Fri, January 10, 2020
Thu, January 9, 2020
Wed, January 8, 2020
Tue, January 7, 2020

Matthew O"Brien Upgraded (ZBH) to Buy and Increased Target to $170 on, Jan 7th, 2020


Published on 2024-10-26 19:44:08 - WOPRAI, Matthew O'Brien
  Print publication without navigation


Matthew O"Brien of Piper Sandler, Upgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Buy and Increased Target from $140 to $170 on, Jan 7th, 2020.

Matthew has made no other calls on ZBH in the last 4 months.

There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 0 agree with Matthew"s Rating of Hold.

These are the ratings of the 8 analyists that currently disagree with Matthew;

Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $187 on, Thursday, December 19th, 2019
David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $170 on, Tuesday, December 17th, 2019
Lawrence Keusch of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $170 on, Wednesday, December 4th, 2019
Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $165 on, Wednesday, November 6th, 2019
Shagun Singh of "RBC Capital" Maintained at Buy with Increased Target to $155 on, Wednesday, November 6th, 2019
Ryan Zimmerman of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $158 on, Monday, October 7th, 2019
Kyle Rose of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Increased Target to $167 on, Wednesday, September 18th, 2019
Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $158 on, Monday, September 9th, 2019